Carl Quintanilla, Jim Cramer and David Faber discussed the upward momentum for stocks as we begin a new trading week. The anchors previewed what to expect from this week's bank earnings, with the first results due out Tuesday. They also took a closer look at the stimulus stalemate as talks between Capitol Hill Democrats and the White House on COVID-19 aid relief reach an impasse. Also on the coronavirus front: The moves in stocks such as Regeneron and Lilly, whose antibody cocktails remain in the spotlight.

Carl, Jim and David also analyzed this morning's calls by Wall Street firms initiating coverage of cloud company Snowflake. The stock has more than doubled its September IPO price of $120.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.